Mechanical Engineering Professor Alan McGaughey of Carnegie Mellon University recently coordinated the Phonon Olympics, ...
NEW ORLEANS -- The investigational oral PCSK9 inhibitor enlicitide reduced low-density lipoprotein (LDL) cholesterol in ...
The medication, which significantly lowers the risk of heart attacks, could be a promising alternative to expensive and ...
Among people with a previous heart attack or stroke, or who are at high risk for one, a daily oral medication may offer an effective alternative to injections of PCSK9 inhibitors to lower low-density ...